Summary:
In this webinar, you will see Dr Elizabeth M Jaffee, Johns Hopkins University, present data from studies of vaccine plus immune checkpoint combination therapy demonstrating the ability to activate anticancer immune responses in classically resistant cancers, from the 2021 Immuno-Oncology 360° Conference.
To learn more about the Immuno-Oncology 360° Conference, please visit IO360Summit.com.